Coloplast A/S Stock
Stocks
COLO B
DK0060448595
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 415.30 DKK | -0.62% |
|
-1.26% | -23.99% |
| 09-09 | JP Morgan cuts Coloplast, puts Ambu and Elekta on negative watch - BN | FW |
| 09-09 | JP Morgan downgrades Coloplast to underweight (neutral) - BN | FW |
| Market Cap | 93.51B 14.08B 12.5B 11.69B 10.65B 20.06B 1,355B 20.34B 141B 54.76B 690B 52.85B 51.71B 2,217B | P/E 2026 * |
26.8x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 114B 17.15B 15.23B 14.24B 12.98B 24.44B 1,651B 24.77B 172B 66.7B 841B 64.38B 62.99B 2,701B | EV / Sales 2026 * |
3.95x | EV / Sales 2027 * | 3.67x |
| Free-Float |
63.42% | Yield 2026 * |
4.91% | Yield 2027 * | 5.21% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| COLO B | Delayed | |
CBOE
| COLOBc | Real-time | |
Tradegate
| CBHD | Real-time | |
London S.E.
| 0QBO | Delayed | |
Xetra
| CBHD | Delayed | |
Berne S.E.
| 020259063 | End-of-day quote | |
OTC Markets
| CLPBF | Delayed | |
Deutsche Boerse AG
| CBHD | Delayed | |
CBOE
| 0QBO | Real-time | |
Wiener Boerse
| COLO | End-of-day quote | |
Börse Stuttgart
| CBHD | Delayed | |
Boerse Muenchen
| CBHD | Real-time |
Last Transcript: Coloplast A/S
| 1 day | -0.62% | ||
| 1 week | -1.26% | ||
| Current month | -0.62% | ||
| 1 month | -11.53% | ||
| 3 months | +9.66% | ||
| 6 months | -6.21% | ||
| Current year | -23.99% |
| 1 week | 407.6 | 424.2 | |
| 1 month | 407.6 | 479.1 | |
| Current year | 369.7 | 584.2 | |
| 1 year | 369.7 | 631.4 | |
| 3 years | 369.7 | 977.6 | |
| 5 years | 369.7 | 1,194 | |
| 10 years | 369.7 | 1,194 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Wood
CEO | Chief Executive Officer | 55 | 2026-04-30 |
| Director of Finance/CFO | 54 | 2005-12-31 | |
Allan Rasmussen
COO | Chief Operating Officer | 59 | 2008-09-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 2006-12-12 | |
Thomas Barfod
BRD | Director/Board Member | 56 | 2009-09-17 |
| Chairman | 58 | 2025-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/22 | Buy | Company | 27,398 | 0.0138% | ||
| 4/4/22 | Buy | Company | 393,288 | 0.1986% | ||
| 3/28/22 | Buy | Company | 3,552 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.62% | -1.26% | -25.52% | -44.45% | 14.08B | ||
| -2.17% | -4.33% | -27.56% | -0.17% | 167B | ||
| +0.17% | -2.34% | -8.83% | +10.31% | 111B | ||
| -0.88% | +1.19% | -25.04% | -0.11% | 105B | ||
| -0.69% | -0.07% | -47.78% | -12.45% | 74.82B | ||
| +3.17% | -0.03% | -0.64% | +72.13% | 59.11B | ||
| -1.15% | +2.53% | +13.10% | +58.84% | 51.8B | ||
| -0.52% | -0.65% | -6.74% | -31.12% | 48.5B | ||
| -0.85% | +0.85% | -16.51% | +18.41% | 40.79B | ||
| -0.07% | -1.42% | +30.49% | -7.58% | 32.54B | ||
| Average | -0.37% | -0.27% | -11.50% | +6.38% | 70.42B | |
| Weighted average by Cap. | -0.62% | -0.92% | -16.34% | +8.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.86B 4.34B 3.86B 3.61B 3.29B 6.19B 418B 6.27B 43.65B 16.9B 213B 16.31B 15.95B 684B | 30.81B 4.64B 4.12B 3.85B 3.51B 6.61B 446B 6.7B 46.6B 18.04B 227B 17.41B 17.03B 730B |
| Net income | 3.55B 534M 474M 444M 404M 761M 51.43B 772M 5.37B 2.08B 26.19B 2.01B 1.96B 84.13B | 5.85B 880M 782M 731M 666M 1.25B 84.72B 1.27B 8.84B 3.42B 43.15B 3.3B 3.23B 139B |
| Net Debt | 20.4B 3.07B 2.73B 2.55B 2.32B 4.38B 296B 4.44B 30.86B 11.95B 151B 11.53B 11.28B 484B | 19.59B 2.95B 2.62B 2.45B 2.23B 4.2B 284B 4.26B 29.63B 11.47B 145B 11.07B 10.83B 464B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-01 | DKK 415.30 | -0.62% | 304,634 |
| 26-09-30 | DKK 417.90 | -0.26% | 334,274 |
| 26-09-29 | DKK 419.00 | -0.43% | 279,690 |
| 26-09-28 | DKK 420.80 | +0.77% | 323,630 |
| 26-09-25 | DKK 417.60 | -0.71% | 362,766 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLO B Stock
Select your edition
All financial news and data tailored to specific country editions


















